Quidel | QDEL - Operating Expenses


Quidel reported $1.85B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Abbott USD 9.31B 104M Mar/2026
Agilent USD 1.44B 9M Mar/2026
Avanos Medical USD 782.1M 625.97M Mar/2026
Becton, Dickinson and Co. USD 24.13B 19.54B Mar/2026
Bruker USD 813.2M 87.7M Mar/2026
Cerus USD 34.78M 2.98M Dec/2024
Charles River Laboratories USD 875.93M 42.48M Mar/2026
Danaher USD 52.95B 47.61B Mar/2026
Haemonetics USD 134.99M 1.26M Dec/2025
Illumina USD 852M 51M Mar/2026
IQVIA Holdings USD 6.22B 4.53B Mar/2026
Merit Medical Systems USD 337.72M 2.02M Mar/2026
Mettler Toledo International USD 713.2M 64.61M Mar/2026
Myriad Genetics USD 212.8M 16.2M Dec/2025
Neogen USD 214.5M 15.57M Dec/2025
OraSure Technologies USD 40.35M 2.45M Dec/2025
Pacific Biosciences Of California USD 97.83M 41.29M Dec/2025
Quidel USD 1.85B 1.09B Mar/2026
Revvity USD 628.34M 2.12M Mar/2026
STAAR Surgical USD 76.12M 7.38M Mar/2026
Thermo Fisher Scientific USD 9.09B 821M Mar/2026
Waters USD 1.12B 457.15M Mar/2026